Detalhe da pesquisa
1.
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
BMC Med
; 14(1): 168, 2016 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27776519
2.
Advances in the development of cancer immunotherapies.
Trends Immunol
; 34(2): 90-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23031830
3.
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
J Immunol
; 189(11): 5476-84, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23105141
4.
2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.
J Biol Chem
; 285(43): 32860-32868, 2010 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20724473
5.
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021033
6.
COVID-19: a pandemic experience that illuminates potential reforms to health research.
EMBO Mol Med
; 12(11): e13278, 2020 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32996267
7.
A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology.
J Immune Based Ther Vaccines
; 6: 1, 2008 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-18321390
8.
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
J Immunother
; 41(9): 399-405, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29757889
9.
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
Clin Cancer Res
; 24(18): 4416-4428, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848573
10.
Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
Clin Cancer Res
; 12(16): 4794-803, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16914564
11.
Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.
Clin Cancer Res
; 12(7 Pt 2): 2359s-2365s, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16609059
12.
Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells.
PLoS One
; 12(8): e0181904, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28837583
13.
Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter.
Clin Cancer Res
; 23(20): 6151-6164, 2017 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754817
14.
4-1BB-Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells.
Cancer Immunol Res
; 5(6): 439-445, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473315
15.
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function.
Cell Res
; 27(8): 1034-1045, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28685773
16.
Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.
Oncotarget
; 7(24): 36074-36091, 2016 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27153543
17.
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity.
Oncoimmunology
; 5(2): e1057386, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27057427
18.
Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
Cancer J
; 21(6): 450-64, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26588676
19.
Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.
BioDrugs
; 29(1): 15-30, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25523015
20.
BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties.
Oncoimmunology
; 4(8): e1014246, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26405566